메뉴 건너뛰기
Rheumatology
Volumn 47, Issue 4, 2008, Pages 548-549
Risk of cancer in Turkish patients after treatment with TNF antagonists

(26)  Pay, S a   Öztürk, M Akif b   Can, Gerçek c   Cefle, Ayşe d   Çobankara, Veli e   Erer, Burak f   Göǧüş, Feride b   Hatemi, Gülen g   Inanç, Nevsum h   Karaaslan, Yaşar i   Karadaǧ, Ömer j   Krakoç, Yüksel k   Kasapoǧlu, Esen l   Kaşifoǧlu, Timuçin m   Keser, Gökhan n   Koca, Serdar o   Öktem, Selda p   Özer, Hüseyin T E q   Sayarhoǧlu, Mehmet r   Soy, Mehmet s   more..

Author keywords

[No Author keywords available]
Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;
EID: 43049166010     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken026     Document Type: Letter
Times cited : (8)
References (9)
  • 1
    • 2642554059 scopus 로고    scopus 로고
    • Lymphoma in rheumatoid arthritis: The effect of MTX and anti-tumor necrosis factor therapy in 18,572 patients
    • Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of MTX and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50: 1740-51.
    • (2004) Arthritis Rheum , vol.50 , pp. 1740-1751
    • Wolfe, F.1    Michaud, K.2
  • 2
    • 17644374819 scopus 로고    scopus 로고
    • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
    • Geborek P, Bladstrom A, Turesson C et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005;64:699-703.
    • (2005) Ann Rheum Dis , vol.64 , pp. 699-703
    • Geborek, P.1    Bladstrom, A.2    Turesson, C.3
  • 3
    • 27744520447 scopus 로고    scopus 로고
    • Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
    • Askling J, Fored CM, Baecklund E et al. Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1414-20.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1414-1420
    • Askling, J.1    Fored, C.M.2    Baecklund, E.3
  • 4
    • 33749346419 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis
    • Setoguchi S, Solomon DH, Weinblatt ME et al. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2757-64.
    • (2006) Arthritis Rheum , vol.54 , pp. 2757-2764
    • Setoguchi, S.1    Solomon, D.H.2    Weinblatt, M.E.3
  • 5
    • 27744499707 scopus 로고    scopus 로고
    • Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    • Chakravarty EF, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 2005;32:2130-5.
    • (2005) J Rheumatol , vol.32 , pp. 2130-2135
    • Chakravarty, E.F.1    Michaud, K.2    Wolfe, F.3
  • 6
    • 34848893989 scopus 로고    scopus 로고
    • Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study
    • Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95.
    • (2007) Arthritis Rheum , vol.56 , pp. 2886-2895
    • Wolfe, F.1    Michaud, K.2
  • 7
    • 0345490901 scopus 로고    scopus 로고
    • Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: A population based cohort study
    • Feltelius N, Ekbom A, Blomqvist P. Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: A population based cohort study. Ann Rheum Dis 2003;62:1185-8.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1185-1188
    • Feltelius, N.1    Ekbom, A.2    Blomqvist, P.3
  • 8
    • 33747808287 scopus 로고    scopus 로고
    • Risk for malignant lymphoma in ankylosing spondylitis: A nationwide Swedish case-control study
    • Askling J, Klareskog L, Blomqvist P, Fored M, Feltelius N. Risk for malignant lymphoma in ankylosing spondylitis: A nationwide Swedish case-control study. Ann Rheum Dis 2006;65:1184-7.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1184-1187
    • Askling, J.1    Klareskog, L.2    Blomqvist, P.3    Fored, M.4    Feltelius, N.5
  • 9
    • 0035142985 scopus 로고    scopus 로고
    • Incidence in Izmir in 1993-1994: First results from Izmir Cancer Registry
    • Fidaner C, Eser SY, Parkin DM. Incidence in Izmir in 1993-1994: First results from Izmir Cancer Registry. Eur J Cancer 2001;37:83-92.
    • (2001) Eur J Cancer , vol.37 , pp. 83-92
    • Fidaner, C.1    Eser, S.Y.2    Parkin, D.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.